Government of Canada makes important investment to fight antimicrobial resistance (AMR)
Antimicrobials, such as antibiotics, save lives every day. Without effective antimicrobials, common infections could become untreatable and even life-threatening for humans and animals.
As AMR knows no boundaries and poses a threat to people around the world, global commitment, collaboration, and ambitious action is critical to combatting AMR. Today, the Honourable Jean-Yves Duclos, Minister of Health, announced an investment of $6.3 million to Combatting Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator (CARB-X) in support of global and domestic antimicrobial innovation. CARB-X is a non-profit organization and global partnership working to address the threat of antibiotic resistance. CARB-X accelerates innovation by supporting the development of new antibiotics, vaccines, diagnostics, and other preclinical and early-stage development products against antibiotic-resistant infections.
Join the AMR Insights Ambassador Network today!
Connect to over 650 AMR professionals and students in 65 countries!